REFILE-BRIEF-U.S. FDA Grants Breakthrough Therapy Designation for Genentech?s Investi
 

REFILE-BRIEF-U.S. FDA Grants Breakthrough Therapy Designation for Genentech?s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
Sept 4 (Reuters) - Sept 4 (Reuters) - Genentech: * U.S. FDA grants breakthrough therapy designation forGenentech's investigational medicine ACE910 for people withHemophilia A with factor VIII...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...sQ:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...sQ:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/EoJ8cmZ2lRk